Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
This equation is commonly abbreviated as: C1V1 = C2V2
|Publication Number||Title||Priority Date|
|WO-2021122386-A1||Glycolic acid polymer||2019-12-18|
|WO-2021125319-A1||Liquid crystal aligning agent, radical generation film and method for producing in-plane switching liquid crystal cell||2019-12-18|
|WO-2021125327-A1||Method for manufacturing patterned liquid crystal display element||2019-12-18|
|WO-2021125329-A1||Radical generation film-forming composition, radical generation film, and method for manufacturing horizontal-electric-field liquid crystal cell||2019-12-18|
|WO-2021116372-A1||Inhibitors of kdm5a for use in treatment of idiopathic inflammatory myopathies||2019-12-12|
|WO-2021057813-A1||Sulfimide photo-acid generator, photosensitive resin composition, patterning method, use of photosensitive resin composition||2019-09-25|
|EP-3795611-A1||Polyamides and corresponding polymer compositions and articles||2019-09-23|
|WO-2021050702-A1||Kdm inhibitors and uses thereof||2019-09-13|
|WO-2021037850-A1||Polyamides and corresponding polymer compositions, articles and methods for making and using||2019-08-27|
|30737136||2019-06-15||Inhibition of a viral prolyl hydroxylase||Bioorganic & medicinal chemistry|
|22944601||2012-11-01||Selective stabilization of HIF-1α in renal tubular cells by 2-oxoglutarate analogues||The American journal of pathology|
|22875277||2012-10-01||α-Ketoglutarate-related inhibitors of HIF prolyl hydroxylases are substrates of renal organic anion transporters 1 (OAT1) and 4 (OAT4)||Pflugers Archiv : European journal of physiology|
|22917519||2012-09-15||Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C)||Bioorganic & medicinal chemistry letters|
|22858225||2012-09-01||The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines||European journal of medicinal chemistry|
|22420752||2012-06-01||Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor||The FEBS journal|
|22266461||2012-03-01||Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure||Journal of inorganic biochemistry|
|21859681||2012-01-01||Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry||Journal of biomolecular screening|
|22259328||2012-01-01||Poly[[hexa-aqua-(μ(2)-oxalato-κO,O:O,O)bis(μ(3)-pyridine-2,4-dicarboxyl-ato-κN,O:O:O)dicerium(III)] monohydrate]||Acta crystallographica. Section E, Structure reports online|
|22272276||2012-01-01||Biapenem inactivation by B2 metallo β-lactamases: energy landscape of the post-hydrolysis reactions||PloS one|
BOC Sciences can provide a wide variety of raw materials from upstream lines for automotive parts manufacturing, such as monomers, polymers and additives.
BOC Sciences supplies the necessary raw materials to help you manufacture ideal composites.
BOC Sciences can help our customers further understand the functionality and applicable requirements for raw materials in different healthcare segments.
BOC Sciences' seasoned experts can help you from upstream lines to arrive at the most appropriate solution to improve production and optimize your bottom line.